Pure Global

Bondis Oppro C1 Deactivator Analysis Kit - Taiwan Registration 52e5e87c50ee975d53893be204eecdca

Access comprehensive regulatory information for Bondis Oppro C1 Deactivator Analysis Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 52e5e87c50ee975d53893be204eecdca and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
52e5e87c50ee975d53893be204eecdca
Registration Details
Taiwan FDA Registration: 52e5e87c50ee975d53893be204eecdca
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Bondis Oppro C1 Deactivator Analysis Kit
TW: ้‚ฆ่ฟชๆ–ฏๆญๆ™ฎ็พ…C1ๅŽปๆดปๅŒ–ๅŠ‘ๅˆ†ๆžๅฅ—็ต„
Risk Class 2

Registration Details

52e5e87c50ee975d53893be204eecdca

DHA05603465603

Company Information

United Kingdom

Product Details

This product is used with the Bondis Optilite analyzer for in vitro quantification of C1 deactivators present in serum.

C Immunology and microbiology

C.5250 ่ฃœ้ซ”C1ๆŠ‘ๅˆถๅŠ‘(ๅŽปๆดปๅŒ–ๅŠ‘)ๅ…็–ซ่ฉฆ้ฉ—็ณป็ตฑ

Input;; QMS/QSD

Dates and Status

May 18, 2021

May 18, 2026